PMV Pharmaceuticals (PMVP) Capital Expenditures (2020 - 2025)
PMV Pharmaceuticals' Capital Expenditures was $15,000 in Q4 2025, down 73.2% from $56,000 a year earlier.
Powered by 
Analysis
PMV Pharmaceuticals (PMVP) Capital Expenditures (2020 - 2025) Analysis & Trends
For FY2025, Capital Expenditures at PMV Pharmaceuticals came in at $29,000, down 95.6% from FY2024.
- Capital Expenditures has now declined for three consecutive years, with a five-year compound annual growth rate of -27.8% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $655,000 in FY2024 (-31.9%), $962,000 in FY2023 (-88.0%), $7.98 million in FY2022 (+474.0%) and $1.39 million in FY2021 (+839.9%).
- Quarterly Capital Expenditures has moved between -$1,000 (Q3 2025) and $2.86 million (Q2 2022) over five years.
- Compared with a year earlier, Capital Expenditures was higher in two of the last seven quarters, with an average decline of 23.8%.
- The best year-over-year quarter for Capital Expenditures over five years was Q2 2022 (growth of 513.7%); the worst was Q1 2025 (a decline of 99.3%).
- Per Business Quant data, PMVP's Capital Expenditures in the three quarters before Q4 2025 was -$1,000 (Q3 2025), $11,000 (Q2 2025) and $4,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | PMV Pharmaceuticals | 89.28 Mn | -325.89 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 15,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 594,000.00 |
| Dec 31, 2023 | 197,000.00 |
| Sep 30, 2023 | 44,000.00 |
| Jun 30, 2023 | 423,000.00 |
| Mar 31, 2023 | 298,000.00 |
| Dec 31, 2022 | 1.64 Mn |
| Sep 30, 2022 | 2.05 Mn |
| Jun 30, 2022 | 2.86 Mn |
| Mar 31, 2022 | 1.44 Mn |
| Dec 31, 2021 | 304,000.00 |
| Sep 30, 2021 | 501,000.00 |
| Jun 30, 2021 | 466,000.00 |
| Mar 31, 2021 | 120,000.00 |
API Access
PMV Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PMVP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PMVP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PMVP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();